Unique ID issued by UMIN | UMIN000014793 |
---|---|
Receipt number | R000017163 |
Scientific Title | Effects of high beta-glucan barley rice on visceral fat obesity in Japanese subjects. A randomized double blind placebo-controlled study |
Date of disclosure of the study information | 2014/08/08 |
Last modified on | 2014/12/26 17:33:25 |
Effects of high beta-glucan barley rice on visceral fat obesity in Japanese subjects. A randomized double blind placebo-controlled study
Effects of high beta-glucan barley rice on visceral fat obesity
Effects of high beta-glucan barley rice on visceral fat obesity in Japanese subjects. A randomized double blind placebo-controlled study
Effects of high beta-glucan barley rice on visceral fat obesity
Japan |
visceral fat obesity
Endocrinology and Metabolism | Adult |
Others
NO
To investigate the effects of high beta-glucan barley rice intake for 12 weeks on visceral fat accumulation
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
change in visceral fat area
1) body weight, waist circumference, subcutaneous fat area, total fat area
2) total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol
3) HbA1c, insulin, free fatty acid, fasting blood sugar
4) leptin, adiponectin
5) blood pressure
6) questionnaire survey about eating behavior and psychosomatic state
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Food |
intake of 200 grams of high beta-glucan barley rice twice daily for 12 weeks
intake of 200 grams of barley rice without beta-glucan twice daily for 12 weeks
30 | years-old | <= |
70 | years-old | > |
Male and Female
1) age between 30 and 70 years old at consent
2) waist circumference >=85 cm (man), >=90 cm (woman)
3) subjects understand the study procedures and agree to participate in the study by giving informed consent prior to the study.
1) experienced body weight changes >= 10% within a year before the start date of this study
2) attended another clinical study within a month before the start date of this study
3) Fasting blood sugar >=126 mg/dl or HbA1c (NGSP) >=6.5% or diabetic patient
4) has history of serious cardiovascular diseases
5) has history of surgery in gastrointestinal tract
6) takes drugs to treat dyslipidemia
7) has continuous intake of dietary fiber supplement or beta glucan (barley, mushroom, black yeast, etc)
8) has continuous intake of Divaricate Saposhnikovia Miraculous Powder
9) has serious liver or kidney disease
10) has history of malignant diseases
11) has serious infectious diseases
12) pregnant or lactating woman
13) allergic to raw materials
14) is not appropriate in the investigator's opinion
100
1st name | |
Middle name | |
Last name | Katsuyuki Miura |
Osaka City University Medical School
Applied Pharmacology and Therapeutics
1-4-3 Asahimachi, Abeno, Osaka
06-6645-3787
miura-pha@med.osaka-cu.ac.jp
1st name | |
Middle name | |
Last name | Hisako Fujii |
Osaka city University Hospital
Center for Drug & Food Clinical Evaluation
1-2-7 Asahimachi, Abeno, Osaka
06-6645-3443
hfujii@med.osaka-cu.ac.jp
Osaka city University Hospital
Faculty of Home Economics, Otsuma Women's University
Other
Japan
NO
大阪市立大学医学部附属病院 Osaka City University Hospital
2014 | Year | 08 | Month | 08 | Day |
Unpublished
Completed
2014 | Year | 07 | Month | 30 | Day |
2014 | Year | 08 | Month | 23 | Day |
2014 | Year | 11 | Month | 30 | Day |
2014 | Year | 12 | Month | 26 | Day |
2014 | Year | 12 | Month | 26 | Day |
2014 | Year | 08 | Month | 08 | Day |
2014 | Year | 12 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017163